|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
However, problems have not been documented with intake of normal daily recommended amounts.
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
Hypercalcemic syndrome, acute |
|
renal calculi, calcific |
|
Constipation, severe |
|
dryness of mouth |
|
headache, continuing |
|
increased thirst |
|
irritability |
|
loss of appetite |
|
mental depression |
|
metallic taste |
|
unusual tiredness or weakness |
|
Confusion |
|
drowsiness |
|
high blood pressure |
|
increased sensitivity of eyes or skin to light, especially in hemodialysis patients |
|
irregular, fast, or slow heartbeat |
|
nausea and vomiting |
|
unusually large amount of urine or increased frequency of urination |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
>> Dehydration |
|
Electrolyte imbalance, other |
|
Diarrhea |
|
Malabsorption, gastrointestinal, chronic |
|
>> Renal calculi |
|
>> Renal function impairment, chronic |
|
|
ADULT DOSE:
|
|
Hypocalcemia (prophylaxis)-Oral, amount based on normal daily recommended intakes:
Persons U.S. Canada
(mg) (mg)
Adolescent and adult males 800-1200 800-1100
Adolescent and adult females 800-1200 700-1100
Pregnant females 1200 1200-1500
Breast-feeding females 1200 1200-1500
Hypocalcemia (treatment)-Treatment dose is individualized by prescriber based on severity of deficiency |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Hypocalcemia (prophylaxis)-Oral, amount based on normal daily recommended intakes:
Persons U.S. Canada
(mg) (mg)
Infants and children 400-800 250-550
Birth to 3 years of age
4 to 6 years of age 800 600
7 to 10 years 800 700-1100
Hypocalcemia (treatment)-Treatment dose is individualized by prescriber based on severity of deficiency. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|